Target intelligence / Profile preview

Intersectin-1 (ITSN1)

Target
ITSN1
Molecular classification
Scaffold/adaptor protein, Guanine nucleotide exchange factor (GEF) (ITSN1-L, but not all isoforms), Cytoplasmic membrane-associated protein, Other (multi-domain protein, involved in endocytosis and cytoskeletal reorganization)
01

Overview

Intersectin-1 is a multi-domain, cytoplasmic membrane-associated scaffold protein encoded by the ITSN1 gene. It acts as an adaptor linking endocytic membrane trafficking with the actin cytoskeleton and coordinates the formation of clathrin-coated vesicles, synaptic vesicle recycling, and various signal transduction pathways[1][3][7]. ITSN1 exists in long (ITSN1-L) and short (ITSN1-S) isoforms due to alternative splicing, with some isoforms serving as guanine nucleotide exchange factors (GEFs) for small GTPases like Cdc42[2][5]. The protein is involved in neuronal development, dendritic spine morphology, and interacts with multiple partners such as dynamin, CDC42, EPS15, and endophilin, integrating endocytic processes with actin cytoskeleton dynamics and signaling[1][3][4][5][7]. Misregulation or mutation of ITSN1 has been linked to cancer progression and some neurodegenerative diseases, including Alzheimer's disease and Down syndrome[3][5]. There are currently no drugs directly targeting Intersectin-1, and it is not considered a traditional therapeutic receptor, enzyme, or transporter.

Other names
Intersectin-1ITSN1SH3 domain-containing protein 1ASH3D1ASH3P17human intersectin-SH3 domain-containing protein SH3P17Src homology 3 domain-containing proteinMGC134948MGC134949
02

Biological functions

Regulation of endocytosis (clathrin-mediated and caveolar)Actin cytoskeleton organization and rearrangementSignal transduction (links receptor signaling to vesicular trafficking)Vesicle transport and synaptic vesicle recyclingRegulation of dendritic spine development (neuronal function)
03

Disease associations

Cancer (misregulation in breast, lung, neuroblastoma, gliomas)Neurodegenerative disease (altered expression in Down syndrome, Alzheimer’s disease)Other (neuronal development disorders, synaptic dysfunction)

Beyond the preview

Go deeper on Intersectin-1 (ITSN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intersectin-1 (ITSN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call